Have a personal or library account? Click to login
Effect of Propranolol on Motor Cortex Excitability in Essential Tremor: An Exploratory Study Cover

Effect of Propranolol on Motor Cortex Excitability in Essential Tremor: An Exploratory Study

Tremor and Other Hyperkinetic Movements
Volume 14 (2024): Issue 1
By: Adán Miguel-Puga,  Gabriel Villafuerte,  Mario Treviño,  Emmanuel Ortega-Robles and  Oscar Arias-Carrión  
Open Access
|Jan 2024

References

  1. 1Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC. A New Adrenergic Betareceptor Antagonist. Lancet (London, England). 1964; 1(7342): 1080–1. DOI: 10.1016/S0140-6736(64)91275-9
    Back to article
  2. 2Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ (Clinical research ed). 1999; 318(7200): 1730–7. DOI: 10.1136/bmj.318.7200.1730
    Back to article
  3. 3Zhang Y, Sun N, Jiang X, Xi Y. Comparative efficacy of beta-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis. Journal of the American Society of Hypertension: JASH. 2017; 11(7): 394–401. DOI: 10.1016/j.jash.2017.05.001
    Back to article
  4. 4Levitt DG. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol. BMC clinical pharmacology. 2002; 2(5). DOI: 10.1186/1472-6904-2-5
    Back to article
  5. 5Louis ED, Ottman R. How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data. Tremor and other hyperkinetic movements (New York, NY). 2014; 4: 259. DOI: 10.5334/tohm.198
    Back to article
  6. 6Dogu O, Sevim S, Camdeviren H, Sasmaz T, Bugdayci R, Aral M, et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology. 2003; 61(12): 1804–6. DOI: 10.1212/01.WNL.0000099075.19951.8C
    Back to article
  7. 7Seijo-Martinez M, Del Rio MC, Alvarez JR, Prado RS, Salgado ET, Esquete JP, et al. Prevalence of Essential Tremor on Arosa Island, Spain: a Community-based, Door-to-Door Survey. Tremor and other hyperkinetic movements (New York, NY). 2013; 3. DOI: 10.5334/tohm.130
    Back to article
  8. 8Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Movement disorders: official journal of the Movement Disorder Society. 1998; 13(Suppl 3): 2–23. DOI: 10.1002/mds.870131303
    Back to article
  9. 9Louis ED. Essential tremor and the cerebellum. Handbook of clinical neurology. 2018; 155: 245–58. DOI: 10.1016/B978-0-444-64189-2.00016-0
    Back to article
  10. 10Critchley M. Observations on essential (heredofamilial) tremor. Brain. 1949; 72(2): 26. DOI: 10.1093/brain/72.2.113
    Back to article
  11. 11Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. 2018; 33(1): 75–87. DOI: 10.1002/mds.27121
    Back to article
  12. 12Taylor EA, Jefferson D, Carroll JD, Turner P. Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists. British journal of clinical pharmacology. 1981; 12(4): 549–59. DOI: 10.1111/j.1365-2125.1981.tb01264.x
    Back to article
  13. 13Loder E, Rizzoli P. Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018. Headache; 2018. DOI: 10.1111/head.13375
    Back to article
  14. 14Giustino TF, Fitzgerald PJ, Maren S. Revisiting propranolol and PTSD: Memory erasure or extinction enhancement? Neurobiology of learning and memory. 2016; 130: 26–33. DOI: 10.1016/j.nlm.2016.01.009
    Back to article
  15. 15Ravaris CL, Friedman MJ, Hauri PJ, McHugo GJ. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. Journal of clinical psychopharmacology. 1991; 11(6): 344–50. DOI: 10.1097/00004714-199112000-00003
    Back to article
  16. 16Meibach RC, Dunner D, Wilson LG, Ishiki D, Dager SR. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial. The Journal of clinical psychiatry. 1987; 48(9): 355–8.
    Back to article
  17. 17Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of psychopharmacology (Oxford, England). 2016; 30(2): 128–39. DOI: 10.1177/0269881115612236
    Back to article
  18. 18Pugh CR, Steinert J, Priest RG. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication. The British journal of psychiatry: the journal of mental science. 1983; 143: 151–5. DOI: 10.1192/bjp.143.2.151
    Back to article
  19. 19Sagar-Ouriaghli I, Lievesley K, Santosh PJ. Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders. Journal of psychopharmacology (Oxford, England). 2018; 32(6): 641–53. DOI: 10.1177/0269881118756245
    Back to article
  20. 20Zappia M, Albanese A, Bruno E, Colosimo C, Filippini G, Martinelli P, et al. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. Journal of neurology. 2013; 260(3): 714–40. DOI: 10.1007/s00415-012-6628-x
    Back to article
  21. 21Hedera P. Emerging strategies in the management of essential tremor. Therapeutic advances in neurological disorders. 2017; 10(2): 137–48. DOI: 10.1177/1756285616679123
    Back to article
  22. 22Abila B, Wilson JF, Marshall RW, Richens A. The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment. British journal of clinical pharmacology. 1985; 20(4): 369–76. DOI: 10.1111/j.1365-2125.1985.tb05079.x
    Back to article
  23. 23Mahabir M, Tucholka A, Shin LM, Etienne P, Brunet A. Emotional face processing in post-traumatic stress disorder after reconsolidation impairment using propranolol: A pilot fMRI study. Journal of anxiety disorders. 2015; 36: 127–33. DOI: 10.1016/j.janxdis.2015.10.004
    Back to article
  24. 24Narayanan A, White CA, Saklayen S, Scaduto MJ, Carpenter AL, Abduljalil A, et al. Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study. Brain imaging and behavior. 2010; 4(2): 189–97. DOI: 10.1007/s11682-010-9098-8
    Back to article
  25. 25Paschalis A, Churchill L, Marina N, Kasymov V, Gourine A, Ackland G. beta1-Adrenoceptor distribution in the rat brain: an immunohistochemical study. Neuroscience letters. 2009; 458(2): 84–8. DOI: 10.1016/j.neulet.2009.04.023
    Back to article
  26. 26Nicholas AP, Pieribone VA, Hokfelt T. Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience. 1993; 56(4): 1023–39. DOI: 10.1016/0306-4522(93)90148-9
    Back to article
  27. 27Nicholson R, Dixon AK, Spanswick D, Lee K. Noradrenergic receptor mRNA expression in adult rat superficial dorsal horn and dorsal root ganglion neurons. Neuroscience letters. 2005; 380(3): 316–21. DOI: 10.1016/j.neulet.2005.01.079
    Back to article
  28. 28Rankovic V, Landgraf P, Kanyshkova T, Ehling P, Meuth SG, Kreutz MR, et al. Modulation of calcium-dependent inactivation of L-type Ca2+ channels via beta-adrenergic signaling in thalamocortical relay neurons. PloS one. 2011; 6(12): e27474. DOI: 10.1371/journal.pone.0027474
    Back to article
  29. 29Baker MR, Baker SN. Beta-adrenergic modulation of tremor and corticomuscular coherence in humans. PloS one. 2012; 7(11): e49088. DOI: 10.1371/journal.pone.0049088
    Back to article
  30. 30Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003; 2(3): 145–56. DOI: 10.1016/S1474-4422(03)00321-1
    Back to article
  31. 31Ziemann U, Reis J, Schwenkreis P, Rosanova M, Strafella A, Badawy R, et al. TMS and drugs revisited 2014. Clinical Neurophysiology. 2015; 126(10): 1847–68. DOI: 10.1016/j.clinph.2014.08.028
    Back to article
  32. 32Veale JF. Edinburgh Handedness Inventory – Short Form: a revised version based on confirmatory factor analysis. Laterality. 2014; 19(2): 164–77. DOI: 10.1080/1357650X.2013.783045
    Back to article
  33. 33Shand DG. Pharmacokinetics of propranolol: a review. Postgraduate medical journal. 1976; 52 Suppl 4: 22–5.
    Back to article
  34. 34Hedera P, Cibulcik F, Davis TL. Pharmacotherapy of essential tremor. Journal of central nervous system disease. 2013; 5: 43–55. DOI: 10.4137/JCNSD.S6561
    Back to article
  35. 35Boutron I, Estellat C, Guittet L, Dechartres A, Sackett DL, Hrobjartsson A, et al. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS medicine. 2006; 3(10): e425. DOI: 10.1371/journal.pmed.0030425
    Back to article
  36. 36Elble R, Bain P, Forjaz MJ, Haubenberger D, Testa C, Goetz CG, et al. Task force report: scales for screening and evaluating tremor: critique and recommendations. Movement disorders: official journal of the Movement Disorder Society. 2013; 28(13): 1793–800. DOI: 10.1002/mds.25648
    Back to article
  37. 37Groppa S, Oliviero A, Eisen A, Quartarone A, Cohen LG, Mall V, et al. A practical guide to diagnostic transcranial magnetic stimulation: Report of an IFCN committee. Clinical Neurophysiology. 2012; 123(5): 858–82. DOI: 10.1016/j.clinph.2012.01.010
    Back to article
  38. 38Moller C, Arai N, Lucke J, Ziemann U. Hysteresis effects on the input-output curve of motor evoked potentials. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. 2009; 120(5): 1003–8. DOI: 10.1016/j.clinph.2009.03.001
    Back to article
  39. 39Louis ED, Barnes L, Wendt KJ, Ford B, Sangiorgio M, Tabbal S, et al. A teaching videotape for the assessment of essential tremor. Movement disorders: official journal of the Movement Disorder Society. 2001; 16(1): 89–93. DOI: 10.1002/1531-8257(200101)16:1<;89::AID-MDS1001>3.0.CO;2-L
    Back to article
  40. 40Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C, et al. Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychological medicine. 2010; 40(11): 1839–48. DOI: 10.1017/S0033291709992376
    Back to article
  41. 41Perez MA, Cohen LG. Interhemispheric inhibition between primary motor cortices: what have we learned? The Journal of physiology. 2009; 587(Pt 4): 725. DOI: 10.1113/jphysiol.2008.166926
    Back to article
  42. 42Tamás G, Pálvölgyi L, Takáts A, Szirmai I, Kamondi A. Contralateral voluntary hand movement inhibits human parkinsonian tremor and variably influences essential tremor. Neurosci Lett. 2004; 357(3): 187–90. DOI: 10.1016/j.neulet.2003.12.092
    Back to article
  43. 43Remiszewska M, Jastrzębski Z, Czyżewska-Szafran H, Wutkiewicz M, Czarnecki A. Increased activity of the GABAergic system in selected brain areas after chronic propranolol treatment in spontaneously hypertensive rats. Biochem Pharmacol. 1992; 44(3): 465–70. DOI: 10.1016/0006-2952(92)90437-N
    Back to article
  44. 44Zhou J, Luo Y, Zhang J-T, Li M-X, Wang C-M, Guan X-L, et al. Propranolol decreases retention of fear memory by modulating the stability of surface glutamate receptor GluA1 subunits in the lateral amygdala. Br J Pharmacol. 2015; 172(21): 5068–82. DOI: 10.1111/bph.13272
    Back to article
  45. 45Song IU, Ha SW, Yang YS, Chung YA. Differences in Regional Glucose Metabolism of the Brain Measured with F-18-FDG-PET in Patients with Essential Tremor According to Their Response to Beta-Blockers. Korean journal of radiology. 2015; 16(5): 967–72. DOI: 10.3348/kjr.2015.16.5.967
    Back to article
  46. 46Bracco M, Turriziani P, Smirni D, Mangano RG, Oliveri M. Relationship between physiological excitatory and inhibitory measures of excitability in the left vs. right human motor cortex and peripheral electrodermal activity. Neuroscience letters. 2017; 641: 45–50. DOI: 10.1016/j.neulet.2017.01.027
    Back to article
DOI: https://doi.org/10.5334/tohm.829 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 20, 2023
Accepted on: Dec 21, 2023
Published on: Jan 2, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Essential Tremor,
Propranolol,
Transcranial Magnetic Stimulation,
Cortical Excitability,
Noradrenergic Modulation,
Physiopathology

© 2024 Adán Miguel-Puga, Gabriel Villafuerte, Mario Treviño, Emmanuel Ortega-Robles, Oscar Arias-Carrión, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 14 (2024): Issue 1Next article